3.1 By 2030, reduce the global maternal mortality ratio to less than 70 per 100,000 live births

3.2 By 2030, end preventable deaths of newborns and under-five children

  • GRI Indicators: former FP4 (Food Processing Sector Disclosure)

3.3 By 2030, end the epidemics of AIDS, tuberculosis, malaria, and neglected tropical diseases and combat hepatitis, water-borne diseases, and other communicable diseases

3.4 By 2030, reduce by one-third pre-mature mortality from non-communicable diseases (NCDs) through prevention and treatment, and promote mental health and wellbeing

3.5 Strengthen prevention and treatment of substance abuse, including narcotic drug abuse and harmful use of alcohol

  • GRI Indicators: M4, M5

3.6 By 2020, halve global deaths and injuries from road traffic accidents

3.7 By 2030, ensure universal access to sexual and reproductive health care services, including for family planning, information and education, and the integration of reproductive health into national strategies and programs

  • Poverty Footprint Indicators: PF-14.7 iii)

3.8 Achieve universal health coverage (UHC), including financial risk protection, access to quality essential health care services, and access to safe, effective, quality, and affordable essential medicines and vaccines for all

3.9 By 2030 substantially reduce the number of deaths and illnesses from hazardous chemicals and air, water, and soil pollution and contamination


3.a. Strengthen implementation of the Framework Convention on Tobacco Control in all countries as appropriate

3.b. Support research and development of vaccines and medicines for the communicable and non-communicable diseases that primarily affect developing countries, provide access to affordable essential medicines and vaccines, in accordance with the Doha Declaration which affirms the right of developing countries to use to the full the provisions in the TRIPS agreement regarding flexibilities to protect public health and, in particular, provide access to medicines for all

  • Access to Medicine Indicators: B.III.4, C.III.1, E.I.1, E.II.1, E.III.2

3.c. Increase substantially health financing and the recruitment, development and training and retention of the health workforce in developing countries, especially in LDCs and SIDS

  • Access to Medicine Indicators: G.I.3, G.III.3, G.III.4

3.d. Strengthen the capacity of all countries, particularly developing countries, for early warning, risk reduction, and management of national and global health risks

Metric type
Value Type
Research Policy
1035 3194
1008 2999
403 825
645 1430
672 1729
699 1769
720 1912
643 1583
588 1202
876 2114
128 298
640 1466
608 1335
561 1440
672 1436
651 1402
613 1362
709 1544